Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Familial Mediterranean Fever
Interventions
DRUG

colchicine sprinkle capsules

0.3 mg

DRUG

colchicine sprinkle capsules

0.3 mg

Trial Locations (10)

24035

Rambam Medical Center, Haifa

34303

Cerrahpasa Medical Facility, Istanbul

52621

Safra Children's Hospital, Tel Litwinsky

Sheba Medical Center, Tel Litwinsky

84141

Soroka Medical Center, Beersheba

90027

Childrens Hospital Los Angeles, Los Angeles

91031

Pediatric Rheumatology Unit - Shaare Zedek Medical Center, Jerusalem

91120

Hadassah Medical Center, Jerusalem

0010

Center of Medical Genetics and Primary Health Care, Yerevan

06100

Hacettepe University, Ankara

All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT01075906 - Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients | Biotech Hunter | Biotech Hunter